Monitoring of immunoglobulin levels identifies kidney transplant recipients at high risk of infection

American Journal of Transplantation

Volumn 12, Issue 10, 2012, Pages 2763-2773

  Fernandez Ruiz M ^a,b   Lopez Medrano F ^a,b   Varela Pena P ^a   Lora Pablos, D ^a,c   Garcia Reyne A ^a,b   Gonzalez E ^a   Morales, J M ^a   San Juan, R ^a,b   Lumbreras, C ^a,b   Paz Artal, E ^a   Andres A ^a   Aguado, J M ^a,b  

^a HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^b Department of Internal Medicine   (Spain)

^c CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

Author keywords

Humoral immunity; hypogammaglobulinemia; infection; kidney transplantation; outcome; risk factors

Indexed keywords

IMMUNOGLOBULIN;

ACUTE PYELONEPHRITIS; ADULT; ARTICLE; BACTEREMIA; BACTERIAL INFECTION; FEMALE; FOLLOW UP; GRAFT RECIPIENT; HIGH RISK PATIENT; HUMAN; HUMORAL IMMUNITY; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOGLOBULIN DEFICIENCY; INCIDENCE; INFECTION RISK; KIDNEY GRAFT; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RISK FACTOR;

ADULT; AGED; FEMALE; HUMANS; IMMUNOGLOBULINS; INFECTION; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 84867096301     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2012.04192.x     Document Type: Article

References (37)

1. Fishman JA, Issa NC,. Infection in organ transplantation: Risk factors and evolving patterns of infection. Infect Dis Clin North Am 2010; 24: 273-283.
2. Fernández-Ruiz M, Lõpez-Medrano F, Romo EM, et al,. Pre-transplant lymphocyte count predicts the incidence of infection during the first two years after liver transplantation. Liver Transplant 2009; 15: 1209-1216.
3. Carbone J, Micheloud D, Salcedo M, et al,. Humoral and cellular immune monitoring might be useful to identify liver transplant recipients at risk for development of infection. Transplant Infect Dis 2008; 10: 396-402.
4. Doron S, Ruthazer R, Werner BG, Rabson A, Snydman DR,. Hypogammaglobulinemia in liver transplant recipients: Incidence, timing, risk factors, and outcomes. Transplantation 2006; 81: 697-703.
5. Goldfard NS, Avery RK, Goormastic M, et al,. Hypogammaglobulinemia in lung transplant recipients. Transplantation 2001; 71: 242-246.
6. Sarmiento E, Rodríguez-Molina JJ, Fernández-Yánez J, et al,. IgG monitoring to identify the risk for development of infection in heart transplant recipients. Transplant Infect Dis 2006; 8: 49-53.
7. Raskova J, Ghobrial I, Czerwinski DK, Shea SM, Eisinger RP, Raska K Jr,. B-cell activation and immunoregulation in end-stage renal disease patients receiving hemodialysis. Arch Intern Med 1987; 147: 89-93.
8. Pahl MV, Gollapudi S, Sepassi L, Gollapudi P, Elahimehr R, Vaziri ND,. Effect of end-stage renal disease on B-lymphocyte subpopulations, IL-7, BAFF and BAFF receptor expression. Nephrol Dial Transplant 2010; 25: 205-212.
9. Keven K, Sahin M, Kutlay S, et al,. Immunoglobulin deficiency in kidney allograft recipients: Comparative effects of mycophenolate mofetil and azathioprine. Transplant Infect Dis 2003; 5: 181-186.
10. Mawhorter S, Yamani MH,. Hypogammaglobulinemia and infection risk in solid organ transplant recipients. Curr Opin Organ Transplant 2008; 13: 581-585.
11. Boddana P, Webb LH, Unsworth J, Brealey M, Bingham C, Harper SJ,. Hypogammaglobulinemia and bronchiectasis in mycophenolate mofetil-treated renal transplant recipients: An emerging clinical phenomenon? Clin Transplant 2011; 25: 417-419.
12. Pollock CA, Mahony JF, Ibels LS, et al,. Immunoglobulin abnormalities in renal transplant recipients. Transplantation 1989; 47: 952-956.
13. Miller BW, Brennan DC, Korenblat PE, Goss JA, Flye MW,. Common variable immunodeficiency in a renal transplant patient with severe recurrent bacterial infection: A case report and review of the literature. Am J Kidney Dis 1995; 25: 947-951.
14. Wieneke H, Otte B, Lang D, Heidenreich S,. Predictive value of IgG subclass levels for infectious complications in renal transplant recipients. Clin Nephrol 1996; 45: 22-28.
15. Broeders EN, Wissing KM, Hazzan M, et al,. Evolution of immunoglobulin and mannose binding protein levels after renal transplantation: Association with infectious complications. Transplant Int 2008; 21: 57-64.
16. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D,. A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999; 130: 461-470.
17. Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM,. CDC definitions for nosocomial infections, 1988. Am J Infect Control 1988; 16: 128-140.
18. Ljungman P, Griffiths P, Paya C,. Definitions of cytomegalovirus infection and disease in transplant recipients. Clin Infect Dis 2002; 34: 1094-1097.
19. De Pauw B, Walsh TJ, Donnelly JP, et al,. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis 2008; 46: 1813-1821.
20. European Expert Group on Renal Transplantation (EBPG); European Renal Association (ERA-EDTA); European Society for Organ Transplantation (ESOT). European Best Practice Guidelines for Renal Transplantation (part 1). Nephrol Dial Transplant 2000; 15 (Suppl 7): 1-85.
21. Hedeken D, Gibbons RD,. Mixed-effect regression models for binary outcomes. In: Longitudinal Data Analysis. New Jersey: Wiley, 2006: 149-186.
22. Prentice RL, Gloeckler LA,. Regression analysis of grouped survival data with application to breast cancer data. Biometrics 1978; 34: 57-67.
23. Smogorzewski M, Massry SG,. Defects in B-cell function and metabolism in uremia: Role of parathyroid hormone. Kidney Int Suppl 2001; 78: S186-S189.
24. Moser B, Roth G, Brunner M, et al,. Aberrant T cell activation and heightened apoptotic turnover in end-stage renal failure patients: A comparative evaluation between non-dialysis, haemodialysis, and peritoneal dialysis. Biochem Biophys Res Commun 2003; 308: 581-585.
25. Descamps-Latscha B, Herbelin A, Nguyen AT, et al,. Soluble CD23 as an effector of immune dysregulation in chronic uremia and dialysis. Kidney Int 1993; 43: 878-884.
26. Kawut SM, Shah L, Wilt JS, et al,. Risk factors and outcomes of hypogammaglobulinemia after lung transplantation. Transplantation 2005; 79: 1723-1726.
27. Yip NH, Lederer DJ, Kawut SM, et al,. Immunoglobulin G levels before and after lung transplantation. Am J Respir Crit Care Med 2006; 173: 917-921.
28. Boddana P, Webb LH, Unsworth J, Brealey M, Bingham C, Harper SJ,. Hypogammaglobulinemia and bronchiectasis in mycophenolate mofetil-treated renal transplant recipients: An emerging clinical phenomenon? Clin Transplant 2011; 25: 417-419.
29. González-Quintela A, Alende MR, Gamallo R, et al,. Serum immunoglobulins (IgG, IgA, IgM) in chronic hepatitis C. A comparison with non-cirrhotic alcoholic liver disease. Hepatogastroenterology 2003; 50: 2121-2126.
30. Yamani MH, Avery RK, Mawhorter SD, et al,. Hypogammaglobulinemia following cardiac transplantation: A link between rejection and infection. J Heart Lung Transplant 2001; 20: 425-430.
31. Donnelly JP, Blijlevens NM, De Pauw BE,. Infections in the immunocompromised host: General principles. In:, Mandel GL, Bennet JE, Dolin R, eds. Principles and practice of Infectious Diseases (7th ed.). Philadelphia, PA: Elsevier Churchill Livingstone, 2010.
32. Muñoz P, Giannella M, Alcalá L, et al,. Clostridium difficile-associated diarrhea in heart transplant recipients: Is hypogammaglobulinemia the answer? J Heart Lung Transplant 2007; 26: 907-914.
33. Corales R, Chua J, Mawhorter S, et al,. Significant post-transplant hypogammaglobulinemia in six heart transplant recipients: An emerging clinical phenomenon? Transpl Infect Dis 2000; 2: 133-139.
34. Ling X, Xiong J, Liang W, et al,. Can immune cell function assay identify patients at risk of infection or rejection? A meta-analysis. Transplantation 2012; 93: 737-743.
35. Yamani MH, Avery R, Mawhorter SD, et al,. The impact of CytoGam on cardiac transplant recipients with moderate hypogammaglobulinemia: A randomized single-center study. J Heart Lung Transplant 2005; 24: 1766-1769.
36. Sarmiento E, Fernández-Yáñez J, Muñoz P, et al,. Hypogammaglobulinemia after heart transplantation: Use of intravenous immunoglobulin replacement therapy in relapsing CMV disease. Int Immunopharmacol 2005; 5: 97-101.
37. Kuderer NM, Dale DC, Crawford J, Cosler LE, Lyman GH,. Mortality, morbidity, and cost associated with febrile neutropenia in adult cancer patients. Cancer 2006; 106: 2258-2266.